Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity.

Front Pharmacol · 2023 · PMC10352657 · PMID 37469865

Europe PMC DOI

hedged sentence

0.1260

closest p · 2.5× alpha

0.1260

boldest claim

The sentences

did not reach statistical significancep = 0.126not close (p > 0.1)

However, this change did not reach statistical significance [+19.8 (0.4–26.0) vs. +8.4 (5.0–13.3) vs. +5.2 (1.3–7.8), p = 0.126 for ≤P25 vs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.